Abstract
Bilayer tablets are generating great interest recently as they can achieve controlled delivery of different drugs with predefined release profiles. Over the last three decades pharmaceutical industries interested in developing a combination of two or more API′s in a single dosage form for promoting patient convenience and compliance
AVF shortcode render error: Layout is missing (avf-layout name="Article Addons" view-id="66d98451c48e3")